Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 9, 2015, Pages 2296-2304

  Carvajal Yepes, Monica ^a   Sporer, Kelly R B ^a   Carter, Jenna L ^a   Colvin, Christopher J ^a   Coussens, Paul M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

H1N1; Influenza; Interferon; ShRNA; Vaccine production

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; INTERFERON; INTERFERON REGULATORY FACTOR 3; PROTEIN KINASE R; VIRUS NUCLEOPROTEIN; ALPHA BETA INTERFERON RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HEMAGGLUTINATION TEST; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A VIRUS; NONHUMAN; PBS 12S CELL LINE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHICKEN; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; ORTHOMYXOVIRIDAE; PHARMACEUTICS; PROCEDURES; VIRUS CULTURE; VIRUS LOAD;

ANIMALS; CELL LINE; CHICKENS; GENE KNOCKDOWN TECHNIQUES; INTERFERONS; ORTHOMYXOVIRIDAE; RECEPTOR, INTERFERON ALPHA-BETA; RNA, SMALL INTERFERING; TECHNOLOGY, PHARMACEUTICAL; VIRAL LOAD; VIRUS CULTIVATION;

EID: 84954518477     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1016677     Document Type: Article

References (21)

1. World Health Organization (WHO). Fact sheet 211. 2014
2. Genzel Y, Reichl U. Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 2009; 8:1681-92; PMID:19943763; http://dx.doi.org/10.1586/erv.09.128
3. Vlecken DH, Pelgrim RP, Ruminski S, Bakker WA, van der Pol LA. Comparison of initial feasibility of host cell lines for viral vaccine production. J Virol Methods 2013; 193:28-41; PMID:23684847; http://dx.doi.org/10.1016/j.jviromet.2013.04.020
4. Center for Disease Control (CDC). 2012
5. Coussens PM, Smith KA, Weber PS, Colvin CJ. Immortalized chick embryo cell line adapted to serumfree growth conditions and capable of replicating human and reassortant H5N1 influenza strains for vaccine production. Vaccine 2011; 29:8661-8; PMID:21911025; http://dx.doi.org/10.1016/j.vaccine.2011.08.122
6. Smith KA, Colvin CJ, Weber PS, Spatz SJ, Coussens PM. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases. Vaccine 2008; 26:3778-82; PMID:18524432; http://dx.doi.org/10.1016/j.vaccine.2008.04.048
7. Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 2007; 316:71-95; PMID:17969444
8. Jiang H, Yang H, Kapczynski DR. Chicken interferon a pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species. Virol J 2011; 8:447; PMID:21939525; http://dx.doi.org/10.1186/1743-422X-8-447
9. Koerner I, Kochs G, Kalinke U, Weiss S, Staeheli P. Protective role of b interferon in host defense against influenza A virus. J Virol 2007; 81:2025-30; PMID:17151098; http://dx.doi.org/10.1128/JVI.01718-06
10. Grant CE, Vasa MZ, Deeley RG. cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA. Nucleic Acids Res 1995; 23:2137-46; PMID:7541908; http://dx.doi.org/10.1093/nar/23.12.2137
11. Ko JH, Asano A, Kon Y, Watanabe T, Agui T. Characterization of the chicken PKR: polymorphism of the gene and antiviral activity against vesicular stomatitis virus. Jpn J Vet Res 2004; 51:123-33;PMID:15070037
12. Liniger M, Summerfield A, Zimmer G, McCullough KC, Ruggli N. Chicken cells sense influenza A virus infection throughMDA5 and CARDIF signaling involving LGP2. J Virol 2012; 86:705-17
13. ; PMID:22072756; http://dx.doi.org/10.1128/JVI.00742-11
14. Potts JD, Kornacker S, Beebe DC. Activation of the Jak-STAT-signaling pathway in embryonic lens cells. Dev Biol 1998; 204:277-92; PMID:9851859; http://dx.doi.org/10.1006/dbio.1998.9077
15. Schumacher B, Bernasconi D, Schultz U, Staeheli P. The chicken Mx promoter contains an ISRE motif and confers interferon inducibility to a reporter gene in chick and monkey cells. Virology 1994; 203:144-8; PMID:7518167; http://dx.doi.org/10.1006/viro.1994.1464
16. Tatsumi R, Hamada K, Sekiya S, Wakamatsu M, Namikawa T, Mizutani M, Sokawa Y. 20,50- oligoadenylate synthetase gene in chicken: gene structure, distribution of alleles and their expression. Biochim Biophys Acta 2000; 1494:263-8; PMID:11121584; http://dx.doi.org/10.1016/S0167-4781(00)00174-3
17. de Weerd NA, Nguyen T. The interferons and their receptors–distribution and regulation. Immunol Cell Biol 2012; 90:483-91; PMID:22410872; http://dx.doi.org/10.1038/icb.2012.9
18. Goodman AG, Zeng H, Proll SC, Peng X, Cilloniz C, Carter VS, Korth MJ, Tumpey TM, Katze MG. The a/b interferon receptor provides protection against influenza virus replication but is dispensable for inflammatory response signaling. J Virol 2010; 84:2027-37; PMID:19939913; http://dx.doi.org/10.1128/JVI.01595-09
19. Genzel Y, Fischer M, Reichl U. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Vaccine 2006; 24:3261-72; PMID:16472544; http://dx.doi.org/10.1016/j.vaccine.2006.01.019
20. Jia D, Rahbar R, Chan RW, Lee SM, Chan MC, Wang BX, Baker DP, Sun B, Peiris JS, Nicholls JM, et al. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PloS one 2010; 5:e13927; PMID:21085662; http://dx.doi.org/10.1371/journal.pone.0013927
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262